Thesis: BN (Brookfield Corporation) trades at a ~31% discount to its own stated $66/share intrinsic value (Q1-2026 6-K) and ~30-50% to the cluster of independent SOTP/DCF estimates ($51-84). The structural setup is different from the BAM FRE-growth thesis (2026-05-26 BAM deep-dive): BN is the capital-heavy parent carrying ~$268B of (largely non-recourse) debt against a ~$102B market cap, where the return driver is discount-narrowing, not fee growth. The decisive new fact this artifact adds over the BAM cross-comparison: there is now a board-pending corporate-simplification catalyst — management is actively combining BN with its paired insurance security BNT, and explicitly "evaluating a similar simplification plan" for the two infrastructure (BIP/BIPC) and two energy (BEP/BEPC) entities. That is the mechanical re-rate path the BAM deep-dive's open follow-up was waiting on, surfaced from the primary Q1 filing. Beta ~1.85 (vs BAM ~1.25) means the rate-cut cycle is a leveraged re-rate — it cuts both ways.

This is the standalone BN deep-dive filed as a follow-up from the BAM deep-dive (TASKS-RESEARCH.md:37). It extends rather than repeats the BAM artifact's BN cross-comparison; read that artifact's section (a) for the BAM-vs-BN vehicle choice and the carry-economics split investigation for the BN-side carry mechanics (BN gets 100% of mature-fund carry + 33.3% of new-fund carry via Tracking Shares + redeemable NCI).

Tape (2026-05-29 — from the alt-managers scan summaries, data as of 2026-05-29)

Price/RSI/returns are read from the scan summary (code does the math); valuation multiples are from market-data provider figures (2026-05-29 intraday).

The 1Y divergence has widened in BN's favor since the 2026-05-26 BAM snapshot (BN +19.9%→+19.2% holds; BAM −12.3%→−10.4%). The structural fact is unchanged and central: over 1Y the market has paid for the leveraged SOTP-discount parent (BN: +19% with positive 3Y alpha +34.6) and sold the fee-light pure-play (BAM: −10%, alpha −40). BN sits only −8% from its 52w high and above its SMA200 (trend "up"); BAM is −24% from high and below SMA200. Note (split): BN completed a 3-for-2 stock split on 2026-10-09 [sic — Oct 9, 2025]; all per-share figures below are post-split.

Q1-2026 operating snapshot (BN's own 6-K, filed 2026-05-14)

Primary source — the 6-K itself, not market-data providers. These are the numbers the SOTP and the intrinsic-value claim rest on:

The headline fact: BN repurchased its own shares at ~$41 — which it states is "an approximate 40% discount to our view of intrinsic value at quarter end of $66." Management is putting balance-sheet cash behind the discount thesis. At today's $45.59 the discount to BN's own $66 is ~31%.

(a) Primary SOTP build

BN does not publish a single clean per-share SOTP table in the 6-K, but the pieces are observable from listed-affiliate market caps (2026-05-29) plus BN's disclosed ownership and the $66 management intrinsic value. Two builds below — a conservative market-implied build (mark the listed stakes to market, haircut the private pieces) and the management plan-value anchor.

BN's disclosed/known ownership of the listed affiliates:

• BAM — ~73% combined economic interest (69% direct + 4% via Brookfield Wealth Solutions); confirmed in the Feb-2025 arrangement (BN retains ~73% of 1,637M BAM Class A shares).
• BIP / BIPC (Brookfield Infrastructure) — BN ~26-27% economic.
• BEP / BEPC (Brookfield Renewable) — BN ~46-48% economic.
• BBU / BBUC (Brookfield Business) — BN ~64-68% economic.

Market-implied SOTP (conservative, mark-listed-to-market):

The listed stakes alone (~$83.7B attributable across BAM+BIP+BEP+BBU) already cover ~82% of BN's $101.8B market cap — before assigning any value to Wealth Solutions (~$26-34B), private real estate, Oaktree, or the ~$11.8B unrealized carried-interest pipeline. That is the core SOTP-discount argument: at $45.59 you are paying roughly the listed-stake value and getting the insurance platform, private real assets, credit, and the carry annuity for free (net of recourse corporate debt).

Independent SOTP/intrinsic estimates (triangulation):

The cluster spans ~$51-84 with a central tendency ~$60-66, all above the $45.59 price. Even the most conservative independent SOTP ($50.96) sits ~12% above spot; management's own $66 implies ~45% upside; street's $54.40 implies ~19%. The discount is real on every method; the dispersion is in how much, not whether.

Provenance note. BN is a Canadian-domiciled foreign private issuer (files 40-F / 6-K, not 10-K/10-Q). Massive/Polygon's financials endpoint returned "No results found" for BN on a fresh 2026-05-29 pull (re-confirming the 2026-05-26 BAM-deep-dive behavior; same precedent as ARM). Quarterly fundamentals therefore come from a fallback market-data provider (fetched 2026-05-26), and the operating/intrinsic figures come from the primary BN Q1-2026 6-K pulled from SEC EDGAR. No financials_waiver needed — primary filing + fallback data both cited.

(b) BN-specific catalyst path to discount narrowing

This is where BN diverges hardest from BAM, and the news is fresh in the Q1-2026 6-K:

1. BN/BNT combination (board-pending, the lead catalyst). Management: "The next step is the combination of Brookfield Corporation (BN) and our insurance business (BNT) … the end result will be a fully integrated insurance and investment company … expected to be completed on a tax-efficient basis for most shareholders … the combined business is expected to be listed on the TSX and NYSE and trade under the symbol 'BN'." Final board review "in the coming weeks," with BN and BNT shareholder approvals sought at the respective 2026 annual meetings. This collapses the paired-security complexity that is a direct source of the conglomerate discount. Rationale stated verbatim: "simpler structures with larger market capitalizations are now the most effective way to position these businesses."
2. BIP/BIPC and BEP/BEPC consolidation (signaled, not yet announced). Same paragraph: "We are also evaluating a similar simplification plan for our two infrastructure and our two energy entities." Each paired-corp/paired-LP collapse removes a layer of structural discount. This is a multi-step de-stapling program, not a one-off.
3. Buyback at a stated ~40% discount to intrinsic. $470M BN + $575M BAM repurchased YTD at avg $41 vs the $66 internal mark. Buyback at a self-assessed deep discount is both accretive and a credibility signal that management treats $66 as a real number.
4. Monetization pipeline funding the narrowing. $17B of asset sales executed in Q1 ($6B infra, $5B energy, $2B real estate, $4B other), "substantially all at or above carrying values," + an "active pipeline of monetizations" and $188B deployable capital. Realizations validate carrying values (attacks the discount) and recycle into higher-return deployment.
5. Rate cycle (shared with BAM, but levered at BN). Falling rates compress cap rates on the real-asset book (mark-to-market up) and accelerate LP commitment cadence; BN's 1.85 beta means the percentage re-rate is larger than BAM's.

The catalyst path is more concrete than the BAM deep-dive could state — the BAM artifact's open question "any corporate action at BN (recapitalization, segment spin, simplification) would compress the SOTP discount" is now answered: the simplification is in motion and board-pending.

(c) Beta ~1.85 vs BAM ~1.25 — leverage cuts both ways

BN's beta (1.847) is ~48% higher than BAM's (1.248). The mechanism is the $268B consolidated debt vs $102B market cap (~2.6x debt/equity at the consolidated level). The leverage is largely non-recourse, asset-level, secured against specific infrastructure/renewable/real-estate assets — recourse corporate debt is a far smaller slice (management cites ~$74B of corporate/affiliate/wealth liquidity against it). But the gross number drives the equity's sensitivity:

• Upside (rate-cut / discount-narrowing): a given % move in NAV produces an amplified % move in BN equity vs BAM. In the historical alt-manager cut windows (2019, 2023H2-2024) the cohort ran +30-50% over 6 months on 100-150bp of cuts; BN's 1.85 beta means it leads the cohort on the way up — consistent with the +19% 1Y / +34.6 3Y alpha already on the tape.
• Downside (rate-up / credit stress / realization freeze): the same leverage amplifies drawdowns. If the Fed pauses/reverses or a realization environment freezes, BN's equity takes a larger percentage hit than BAM's, and the discount can widen rather than narrow. The −8% from 52w high understates the potential air pocket: the 52w low of $37.83 is −17% from spot, and a rate-shock scenario could test it.
• Net: BN is the higher-octane expression of the identical underlying Brookfield business. For an investor who believes the rate-cut cycle and the simplification program both land, BN is the better risk/reward (cheaper on every multiple, mechanical re-rate path, levered beta). For an investor who wants the same thesis with lower drawdown risk, BAM is the lower-beta vehicle — but at 22x fwd vs BN's 7.8x fwd you pay a large premium for that lower beta.

(d) Insurance Solutions (Wealth Solutions / BNT) integration risk at the BN level

Wealth Solutions is BN's fastest-scaling and most operationally complex segment, and the BN/BNT combination puts it at the center of the corporate structure — so the integration risk lands at the BN level specifically, not BAM's:

• Scale & contribution: Wealth Solutions DE $430M in Q1 ($1.7B LTM, $0.71/sh) — ~28% of total LTM DE. Annuity sales $4B in the quarter (retail + institutional), insurance asset base "continued expansion." Perpetual capital ~$26B (per independent estimate).
• The structural risk: insurance is an asset/liability-matching business — spread compression, credit losses on the asset side, or actuarial/duration mismatch compound at a 50-100bp annual drag over years if mis-managed. BN funds Wealth Solutions partly to deploy "excess capital to add to its equity base" — i.e., it is a capital sink that consumes balance-sheet capacity, which is exactly the leverage the SOTP-discount and the 1.85 beta reflect.
• The combination changes the risk profile two ways. (i) Reduces structural-discount risk — collapsing the BNT paired security into BN simplifies the entity the market struggles to value, and "enhances capital efficiency and flexibility." (ii) Increases concentration of insurance risk on the BN balance sheet — a fully integrated insurer-investor means insurance asset/liability risk is no longer ring-fenced in a separate paired vehicle; a Wealth Solutions stumble hits BN equity more directly post-combination.
• Comparability tell: management noted that from Q1 they are changing reporting "to allow greater comparability to peers" — an acknowledgment that the bundled "Solutions" segment disclosure has been hard to value (a point the BAM deep-dive flagged as an open question). Cleaner segment disclosure is itself mildly discount-narrowing.

Net: Wealth Solutions is a genuine growth engine (fastest-growing segment, ~$30-40B/yr incremental permanent capital historically) but it is also the segment most capable of a slow-compounding mistake, and the BN/BNT combination raises BN-level exposure to it. Watch the post-combination segment disclosure and the annuity-spread trajectory.

Setup

Conviction: medium. The discount is real and multi-method-confirmed, and the catalyst (BN/BNT combination) is board-pending rather than speculative — that is a genuine upgrade over the BAM artifact's "if a corporate action happens." But the leverage (1.85 beta, $268B consolidated debt) and the dependence on the rate cycle + execution of a multi-step de-stapling program keep this at medium, not high. The downside is a real air pocket if rates back up or a realization environment freezes.

• Entry zone: $42–45 (−8% to −1% from spot $45.59). Current price is acceptable for a starter; the SMA50 at $43.90 is the buyable retest; the conviction-add zone is toward the 52w-low area $38-40.
• Stop: $37 (below the 52w low $37.83 / well below SMA200 $44.85). A break there says the discount is widening (rate shock or credit stress), invalidating the narrowing thesis.
• Target (base): $58 (~+27%; discount narrows toward street consensus ~$54-58 as BN/BNT closes and the rate-cut cadence continues; fwd P/E re-rates from 7.8x toward ~9-10x).
• Target (bull): $72 (~+58%; BN/BNT and BIP/BEP simplification both land, rate-cut cycle accelerates, market closes the gap to management's $66 intrinsic and overshoots toward the DCF/DE-multiple cluster $58-80 as the conglomerate discount compresses).

Relative trade note (vs BAM): the BAM deep-dive concluded "BN is currently the better risk/reward vehicle." This standalone artifact reinforces that — BN is cheaper on every multiple, carries the board-pending simplification catalyst, and has the levered beta into the rate cycle. The trade-off is drawdown risk; BAM is the lower-beta, cleaner-business expression of the identical underlying.

Bull case

• ~31% discount to BN's own $66 intrinsic (and ~12-45% to the independent $51-66 cluster) with management actively buying back stock at a self-assessed ~40% discount — a credible floor and a re-rate runway.
• Board-pending BN/BNT combination mechanically collapses the paired-security complexity that drives part of the conglomerate discount; signaled BIP/BIPC + BEP/BEPC consolidation is a further multi-step de-stapling program.
• Listed stakes alone (~$84B attributable) cover ~82% of market cap — Wealth Solutions (~$26-34B), private real estate, Oaktree, and the $11.8B unrealized carry pipeline are effectively free at spot.
• Distributable earnings compounding — LTM total DE $6.0B ($2.54/sh) +6% YoY; fee-bearing capital $614B +12%; $188B deployable capital + $67B YTD fundraising feed forward growth.
• Levered beta (1.85) into a rate-cut cycle — BN leads the alt-manager cohort on the way up; +19% 1Y / +34.6 3Y alpha already shows the rotation working.
• AI-power-bottleneck adjacency via BIP/BEP — BN is the balance-sheet-leveraged expression of the same data-center / hyperscaler-PPA assets that anchor the ai-power-bottleneck perspective (MSFT $10B BEP PPA; BIP data-center holdings). Direct-asset ownership at BN vs fee-stream-only at BAM.

Bear case

• $268B consolidated debt + 1.85 beta = amplified drawdowns. A Fed pause/reversal or a realization freeze hits BN equity harder than the lower-beta cohort; the 52w low ($37.83, −17%) is a realistic rate-shock test.
• The discount may simply persist. Conglomerate/complexity discounts at multi-affiliate holdcos are sticky; the simplification program is multi-year and execution-dependent. BN has carried a 30-50% SOTP discount for years; "cheap" is not a catalyst by itself.
• Wealth Solutions concentration risk rises post-combination. Insurance asset/liability mismatch or spread compression compounds at 50-100bp/yr; the BN/BNT combination de-ring-fences that risk onto the BN balance sheet.
• Intrinsic value is management-marked. The $66 is BN's own plan value; the most conservative independent SOTP is $50.96 (only ~12% above spot). If the private real-estate / Oaktree / insurance marks are optimistic, the true discount is smaller than the headline.
• Net income is structurally volatile ($73M-$743M across recent quarters; $102M in Q1) because BN absorbs mark-to-market on the real-asset book — GAAP earnings are a poor guide and the 89x TTM P/E is noise, which can spook quant/screener flows.
• FCF is consistently negative at the consolidated level (Q1 FCF −$5.7B; every recent quarter negative FY2025 OCF $10.96B − capex $14.75B = −$3.8B, and −$3.6B in FY2024, per SEC XBRL) — a function of capital recycling/redeployment, not distress, but it requires the monetization pipeline to keep funding the model.

Correction (2026-08-03, D038): the original "Q1 FCF −$5.7B" magnitude was produced by the pre-fix deep-dive resolver (honesty-audit A1: cumulative-YTD quarterly rows summed, investing-cash-flow standing in for capex; code fixed 2026-07-07) and is not a filed figure — a single quarter at −$5.7B would exceed the entire year's deficit. The direction of this bear point survives on filed statements: Brookfield's consolidated OCF-minus-capex was −$3.8B in FY2025 and −$3.6B in FY2024, structurally negative from consolidated real-asset construction spend, which is what the surrounding sentence argues.

• Rate-cycle setup is two-sided — the same rate-sensitivity that drives the bull case reverses on stickier inflation.

Catalysts

• BN/BNT combination board review (coming weeks) + 2026 AGM shareholder votes — the lead discount-narrowing catalyst; approval and close is a re-rate event. (Negative if it stalls or is voted down.)
• BIP/BIPC + BEP/BEPC simplification announcement — formalizing the "evaluating" language into a transaction is a second leg of de-stapling.
• Q2-2026 earnings (~August 2026) — fee-bearing capital trajectory, Wealth Solutions DE, realized carry conversion ($11.8B accumulated; "significant" realization expected over next 3 years).
• Federal Reserve cadence — next FOMC mid-June 2026; each 25bp cut historically ~5-8% relative outperformance for the alt-manager cohort, amplified at BN's beta.
• Continued buybacks — pace of BN repurchases vs the $66 intrinsic mark is an ongoing credibility/accretion signal.
• Monetization prints — sales "at or above carrying value" validate the marks and attack the discount directly.
• Post-combination segment disclosure — cleaner Wealth Solutions / "comparability to peers" reporting is mildly discount-narrowing.

Open questions / follow-ups

• BN/BNT combination terms & close — once final terms are filed (exchange ratio, tax treatment, pro-forma share count), re-run the SOTP on the integrated entity; this artifact pre-dates the definitive agreement.
• Exact affiliate ownership %s — BIP/BEP/BBU economic interests here are ranges from secondary sources; confirm against the FY2025 40-F/AIF or the next supplemental for a precise market-implied SOTP. (BAM 73% is firm; the others are ~26%/~47%/~66% estimates.)
• Watchlist: BN is already in the alt-managers watchlist (created 2026-05-26) with price tracking. No watchlist mutation required. Optional: bargain-bin membership given the explicit SOTP-discount frame — flag for lead, not applied here (producer-only).
• BIP / BEP individual deep-dives remain open from the BAM artifact — the direct-asset AI-power plays; the signaled BIP/BIPC + BEP/BEPC consolidation adds urgency.

Sources

• Tape (price/RSI/returns): alt-managers (precompute, data_as_of 2026-05-29) — BN $45.59, RSI 51.5, +19.19% 1Y, +1.6% vs SMA200, −8.03% from 52w high, beta context. Code-computed; not recomputed in prose.
• Valuation multiples / EV / debt / beta / shares: yfinance info dict, 2026-05-29 intraday pull (BN mkt cap $101.8B, EV $477.2B, total debt $267.5B, fwd P/E 7.77x, beta 1.847, book $19.11/sh) + comparable pulls for BAM/BIP/BIPC/BEP/BEPC/BBU/BBUC for the SOTP build.
• Primary operating + intrinsic value: BN Q1-2026 6-K (filed 2026-05-14), SEC EDGAR Archives/edgar/data/1001085/000117184326003394/exh_991.htm — total DE $1.55B/qtr ($6.0B LTM, $2.54/sh); intrinsic value $66/share; buyback at avg $41 (~40% discount); fee-bearing capital $614B; accumulated unrealized carried interest $11.8B; $188B deployable; BN/BNT combination + BIP/BEP simplification language; $17B Q1 asset sales; 3-for-2 split 2026-10-09 [Oct 9 2025].
• Quarterly fundamentals (fallback): massive{income-statements,balance-sheets,cash-flow-statements}.json(yfinance, fetched 2026-05-26,_source.json` provenance). Massive/Polygon "No results found" for Canadian FPI — re-confirmed via fresh the desk's own tooling on 2026-05-29. Q1-2026: revenue $18.58B, total debt $263.7B, total equity $46.8B, total assets $519.6B, OCF $225M, FCF −$5.68B (FCF figure retracted 2026-08-03 — pre-fix resolver output, not a filed number; see the D038 correction under Bear Case).
• Carry mechanics (BN side): 2026-05-29-bam-bn-carry-economics-split — BN receives 100% mature-fund carry + 33.3% new-fund carry via Relationship Agreement (2022-11-08) + Tracking Shares + redeemable NCI; cites BAM FY2025 10-K + BN FY2025 40-F.
• Cross-comparison base: 2026-05-26-bam-deep-dive (BAM-vs-BN vehicle choice, comp-set, AI-power adjacency). This artifact extends, does not restate, its BN numbers.
• Ownership %s + independent SOTP triangulation: BAM Feb-2025 arrangement disclosure (BN ~73% of 1,637M BAM Class A shares; 69% direct + 4% via Wealth Solutions); analyst consensus avg $54.40 (range $30.98-$60.57); independent SOTP $50.96 / DE-multiple $58.62-$80.14 / DCF $80.35 / EV-weighted $83.94 (Pursuit-of-Compounding, Substack) — secondary, used only for the range of the discount, not as price truth.

Provenance note. BN is a Canadian-domiciled foreign private issuer (40-F / 6-K cadence). Operating/intrinsic figures are from the primary BN Q1-2026 6-K; quarterly statement-level fundamentals are yfinance fallback (Massive returns no results for the FPI — same documented pattern as ARM and the BAM deep-dive). Both paths cited; no financials_waiver required.